5454-82-0

Basic information

• Product Name: Cyclobutylmethylamine hydrochloride
• Synonyms: Cyclobutylmethylamine hydrochloride;CyclobutaneMethanaMine hydrochloride;CyclobutaneMethanaMine, hydrochloride (1:1);(AMinoMethyl)cyclobutane hydrochloride;1-CyclobutylMethylaMine hydrochloride;CyclobutaneMethanaMine HCl;CyclobutylMethylaMine, HCl;(aMinoMethyl)cyclobutane hcl
• CAS NO: 5454-82-0
• Molecular Formula: C₅H₁₁N*ClH
• Molecular Weight: 121.60848
• Mol File: 5454-82-0.mol

Chemical Properties

• Boiling Point: 90.6 °C at 760 mmHg
• Flash Point: 2.1 °C
• Appearance: /
• Density: 0.889 g/cm³
• Storage Temp.: Inert atmosphere,Room Temperature
• Solubility: DMSO (Slightly), Methanol (Slightly), Water (Slightly)
• Stability: Hygroscopic
• CAS DataBase Reference: Cyclobutylmethylamine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclobutylmethylamine hydrochloride(5454-82-0)
• EPA Substance Registry System: Cyclobutylmethylamine hydrochloride(5454-82-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 5454-82-0(Hazardous Substances Data)

Usage

Chemical Properties

White solid

Upstream product

• 4426-11-3 cyclobutanecarbonitrile 

Downstream Products

• 1120-56-5 methylidenecyclobutane 
• 96-41-3 Cyclopentanol 
• 4415-82-1 cyclobutanemethanol 
• 142-29-0 cyclopentene 
• 1613459-68-9 2-cyclobutyl-6-(diethoxymethyl)-3-fluoro-N-tritylpyridin-4-amine 
• 666262-45-9 2-(3-chloro-phenylamino)-4-trifluoromethyl-pyrimidine-5-carboxylic acid cyclobutylmethyl-methyl-amide 
• 666263-14-5 2-(2-methyl-4-chloro-phenylamino)-4-trifluoromethyl-pyrimidine-5-carboxylic acid cyclobutylmethyl-amide 
• 666263-13-4 2-(2-fluoro-3-trifluoromethyl-phenylamino)-4-trifluoromethyl-pyrimidine-5-carboxylic acid cyclobutylmethyl-amide 
• 1582778-48-0 4-(((cyclobutylmethyl)amino)methyl)-3-fluorophenol 

Relevant articles and documents

AMIDE DERIVATIVES AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, formula (I) wherein R1. X, m. R2, Y, R3, Z, n, R4. A and B are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

NOVEL COMPOUNDS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, X, m, R2, Y, R3, Z, n, R4, A and B are as defined in the specification, processes for their prep

BENZIMIDAZOLE ANTIVIRAL AGENTS

Provided are compounds of Formula (I) and (II) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).

PYRIDINE DERIVATIVES AS CONNABINOID RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives such as compounds of the formula (I): and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of t

COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE

Combination of one or more CB2 modulators such as a compound of formula (I), (II) and (III); and one more PDE4 inhibitors are useful of treating conditions which are mediated by the activity of CB2 receptors or conditions which are mediated by PDE4, such

PYRIDINE DERIVATIVES AND THEIR USE AS CB2 RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives such as compounds of the formula (I) and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of th

PYRIMIDINE DERIVATIVES AND THEIR USE AS CB2 MODULATORS

This relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of

3-Morpholino-2-heterocyclic-thiopropanamides

The compounds are 3-morpholino-2-heterocyclicthiopropanamides which are inhibitors of gastric acid secretion.

2-Alkoxy(and 2-alkoxyalkyl)-2-heterocyclic-thioacetamides for inhibiting gastric acid secretion

The compounds are 2-alkoxy(and 2-alkoxyalkyl)-2-heterocyclic-thioacetamides which are inhibitors of gastric acid secretion.

2-Alkoxy(and 2-amino)-3-amino-2-heterocyclic-thiopropanamides

The compounds are 2-alkoxy(and 2-amino)-3-amino-2-heterocyclic-thiopropanamides, for example 2-methoxy-N-methyl-3-morpholino-2-(2-pyridyl)thiopropanamide, which are inhibitors of gastric acid secretion.